The efficacy of photochemical treatment with amotosalen HCl and ultraviolet A (INTERCEPT) for inactivation ofTrypanosoma cruziin pooled buffy‐coat platelets
- 21 February 2007
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 47 (3) , 434-441
Abstract
BACKGROUND:This study evaluated the efficacy of photochemical treatment (PCT) with amotosalen and ultraviolet A (UVA) light to inactivateTrypanosoma cruziin contaminated platelet (PLT) components.STUDY DESIGN AND METHODS:Fifteen pools of buffy‐coat PLTs (BC‐PLTs) were inoculated with approximately 5 × 103to 5 × 105per mL of viableT. cruziof the G, Tulahuen (T), or Y strains. Samples from BC‐PLTs were assayed for infectivity before and after PCT with 150 µmol per L amotosalen and 3 J per cm2UVA light. Infectivity was determined with three different methods: 1) in vitro culture to detect viable epimastigotes, 2) [3H]thymidine incorporation in culture, and 3) in vivo inoculation into interferon‐γ receptor (IFN‐γR)‐deficient mice.RESULTS:The in vitro assay yielded viable parasite titers of 3.9 × 105, 2.8 × 104, and 5.6 × 103per mL (corresponding to 5.6, 4.4, and 3.8 logs/mL) for the Y, T, and G strains, respectively. PCT was able to inactivate all three strains ofT. cruzito below the limit of detection (10 parasites/mL) in the sensitive in vivo assay. Because 10‐mL samples, each concentrated into a 1‐mL sample for inoculation, were tested in the in vivo assay, log reductions achieved were greater than 5.6, greater than 4.4, and greater than 3.8 for the Y, T, and G strains ofT. cruzi, respectively.CONCLUSIONS:The pathogen reduction system with amotosalen HCl and UVA demonstrated robust efficacy for inactivation of high doses of three different strains ofT. cruziand offers the potential to make the PLT supply safer.Keywords
This publication has 24 references indexed in Scilit:
- Photochemical treatment of plasma with amotosalen and long‐wavelength ultraviolet light inactivates pathogens while retaining coagulation functionTransfusion, 2006
- Leishmania inactivation in human pheresis platelets by a psoralen (amotosalen HCl) and long‐wavelength ultraviolet irradiationTransfusion, 2005
- Platelets from pooled buffy coats: an updateTransfusion, 2005
- Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long‐wavelength ultraviolet lightTransfusion, 2005
- Photochemical treatment of platelet concentrates with amotosalen and long‐wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteriaTransfusion, 2004
- Trypanosoma cruziInactivation in Human Platelet Concentrates and Plasma by a Psoralen (Amotosalen HCl) and Long-Wavelength UVAntimicrobial Agents and Chemotherapy, 2003
- Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trialBlood, 2002
- Transfusion-transmitted Chagasʼ diseaseCurrent Opinion in Hematology, 1998
- Prevention of transfusion‐associated Chagas' disease: efficacy of white cell‐reduction filters in removing Trypanosoma cruzi from infected bloodTransfusion, 1995
- Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countriesTransfusion, 1991